018612845

EliVax

---

November 30, 2021

Trademark Summary

The trademark application EliVax was filed by Elixirgen Therapeutics, Inc, a U.S. corporation (the "Applicant"). The application was published for oppositions on January 10, 2022, and it was registered by office on April 19, 2022 without any oppositions.

The application was filed in Dutch (English was selected as the second language).

Change of name and professional address of the trademark registration was recorded on September 18, 2023.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Vaccines for human use
  2. Vaccine for animals
  3. Drug and vaccine for the cancer treatment
  4. Vaccine adjuvants.
• The mark was filed in class 42 with Research and development of vaccines and medicines.
• The mark was filed in class 44 with Inoculation of the vaccine.